S2Medical AB (publ) (STO:S2M)
Sweden · Delayed Price · Currency is SEK 0.0070
-0.0002 (-2.78%)
Sep 2, 2026, 5:29 PM CET
S2Medical AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.56 | 0.91 | 1 | 1.52 | 3.72 | 9.48 |
Cash & Short-Term Investments | 0.56 | 0.91 | 1 | 1.52 | 3.72 | 9.48 |
Cash Growth | -56.21% | -9.73% | -33.78% | -59.25% | -60.72% | -62.56% |
Accounts Receivable | 1.44 | 0.69 | 2.16 | 1.44 | 1.22 | 0.75 |
Other Receivables | 0.32 | 0.23 | 0.17 | 0.38 | 0.41 | 0.51 |
Receivables | 1.77 | 0.92 | 2.33 | 1.82 | 1.63 | 1.26 |
Inventory | 1.3 | 1.37 | 1.68 | 5.16 | 6.39 | 4.62 |
Prepaid Expenses | 0.37 | 0.76 | 0.78 | 0.13 | 0.19 | 0.9 |
Other Current Assets | - | - | - | - | -0 | - |
Total Current Assets | 4 | 3.96 | 5.79 | 8.62 | 11.93 | 16.26 |
Property, Plant & Equipment | 0.15 | 0.2 | 0.43 | 0.75 | 1.19 | 1.74 |
Long-Term Investments | - | - | 7.42 | - | - | - |
Goodwill | - | 0.19 | 0.57 | 0.95 | 1.32 | 1.7 |
Other Intangible Assets | 1.74 | 1.63 | 1.37 | 0.7 | 0.61 | 0.62 |
Long-Term Deferred Charges | 11.01 | 10.92 | 9.77 | 10.39 | 10.24 | 9.35 |
Total Assets | 16.9 | 16.9 | 25.36 | 21.41 | 25.29 | 29.68 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.82 | 0.91 | 0.36 | 3.47 | 1.77 | 0.99 |
Accrued Expenses | 3.06 | 2.98 | 3.15 | 2.66 | 2.45 | 2.16 |
Current Portion of Long-Term Debt | - | - | - | - | - | 0.21 |
Current Income Taxes Payable | - | - | 0.29 | 0.08 | 0.12 | 0.07 |
Other Current Liabilities | 2.96 | 3.14 | 2.84 | 13.53 | 13.88 | 11.57 |
Total Current Liabilities | 6.84 | 7.03 | 6.64 | 19.75 | 18.22 | 15 |
Other Long-Term Liabilities | - | - | - | 0 | - | - |
Total Liabilities | 6.84 | 7.03 | 6.64 | 19.75 | 18.22 | 15 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1.57 | 1.57 | 1.47 | 16.13 | 1.9 | 0.88 |
Additional Paid-In Capital | 121.49 | 121.49 | 120.34 | 120.18 | 104.38 | 83.55 |
Retained Earnings | - | - | - | - | -99.21 | -69.75 |
Comprehensive Income & Other | -113 | -113.19 | -103.08 | -134.66 | - | - |
Shareholders' Equity | 10.06 | 9.87 | 18.72 | 1.66 | 7.07 | 14.68 |
Total Liabilities & Equity | 16.9 | 16.9 | 25.36 | 21.41 | 25.29 | 29.68 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | - | - | - | - | 0.21 |
Net Cash (Debt) | 0.56 | 0.91 | 1 | 1.52 | 3.72 | 9.27 |
Net Cash Growth | -56.21% | -9.73% | -33.78% | -59.25% | -59.85% | -62.14% |
Net Cash Per Share | - | 0.00 | 0.00 | 0.01 | 0.16 | 0.63 |
Filing Date Shares Outstanding | - | 906.78 | 844.26 | 275.45 | 32.49 | 15.05 |
Total Common Shares Outstanding | - | 906.78 | 844.26 | 275.45 | 32.49 | 15.05 |
Working Capital | -2.84 | -3.07 | -0.85 | -11.12 | -6.29 | 1.27 |
Book Value Per Share | - | 0.01 | 0.02 | 0.01 | 0.22 | 0.98 |
Tangible Book Value | 8.33 | 8.06 | 16.78 | 0.01 | 5.13 | 12.36 |
Tangible Book Value Per Share | - | 0.01 | 0.02 | 0.00 | 0.16 | 0.82 |
Machinery | - | 4.08 | 4.05 | 4.05 | 4.05 | 4.55 |